Download PDF

Other users also viewed these articles

Predictors of Malignancy in Patients With Haemoptysis Michele Mondoni; Paolo Carlucci; Giuseppe Cipolla; Nicolò Vanoni; Alessandro Fois; Pietro Pirina; Antonella Arcadu; Stefano Gasparini; Martina Bonifazi; Silvia Marani; Andrea Comel; Laura Saderi; Stefano Pavesi; Fausta Alfano; Rocco Rinaldo; Giulia Veronesi; Stefano Centanni; Giovanni Sotgiu;
Arch Bronconeumol. 2022;58:618-20
Impact of dosing on functional and clinical outcomes of patients with progressive pulmonary fibrosis treated with Nintedanib: data from a real-world, multicentric, Italian study Jacopo Cefalo; Francesco Varone; Fabrizio Luppi; Paolo Cameli; Stefania Cerri; Mariangela Valentina Puci; Alessia Martini; Giovanni Franco; Umberto Zanini; Tommaso Pianigiani; Athina Patsoura; Luca Richeldi; Elena Bargagli; Giovanni Sotgiu; Michele Mondoni;
10.1016/j.arbres.2025.11.005
The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry Jakub Gregor; Yochai Adir; Martina ¿terclová; Nesrin Mogulkoc; Mordechai R. Kramer; Martina Doubková; Martina Pla¿ková; Veronika Müller; Michael Studnicka; Monika ¿urková; Ladislav Lacina; Katarzyna Lewandowska; Vladimír Barto¿; Petra Ovesná; Ond¿ej Májek; Martina Koziar Va¿áková;
Arch Bronconeumol. 2024;60:80-7